Cargando…

Development of a Preclinical Therapeutic Model of Human Brain Metastasis with Chemoradiotherapy

Currently, survival of breast cancer patients with brain metastasis ranges from 2 to 16 months. In experimental brain metastasis studies, only 10% of lesions with the highest permeability exhibited cytotoxic responses to paclitaxel or doxorubicin. Therefore, radiation is the most frequently used tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Aranda, Antonio, Hernández, Vanessa, Picón, Cristina, Modolell, Ignasi, Sierra, Angels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645744/ https://www.ncbi.nlm.nih.gov/pubmed/23591844 http://dx.doi.org/10.3390/ijms14048306

Ejemplares similares

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
por: Martínez-Aranda, Antonio, et al.
Publicado: (2015)

ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
por: de Lucas, Ángel García, et al.
Publicado: (2023)

The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence
por: Nuvoli, Barbara, et al.
Publicado: (2019)

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis
por: Martínez-Aranda, Antonio, et al.
Publicado: (2017)

Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
por: Singh, Mohini, et al.
Publicado: (2017)

Preclinical Studies with Glioblastoma Brain Organoid Co-Cultures Show Efficient 5-ALA Photodynamic Therapy
por: Pedrosa, Leire, et al.
Publicado: (2023)

Re-thinking the preclinical development of GBM therapeutics
por: Cosset, Érika, et al.
Publicado: (2018)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Preclinical Models of Brain Metastases in Breast Cancer
por: Knier, Natasha N., et al.
Publicado: (2022)

GM2-GM3 gangliosides ratio is dependent on GRP94 through down-regulation of GM2-AP cofactor in brain metastasis cells
por: Bedia, Carmen, et al.
Publicado: (2019)

Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
por: Truttmann, Anita C., et al.
Publicado: (2020)

Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseases
por: Bloomingdale, Peter, et al.
Publicado: (2021)

Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells
por: Xiong, Wei, et al.
Publicado: (2020)

Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis
por: Aasen, Synnøve Nymark, et al.
Publicado: (2021)

Preclinical Development of siRNA Therapeutics for AL Amyloidosis
por: Hovey, Beth M., et al.
Publicado: (2011)

Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms
por: Burd, Christin E., et al.
Publicado: (2016)

Developing preclinical models of neuroblastoma: driving therapeutic testing
por: Ornell, Kimberly J., et al.
Publicado: (2019)

Molecular signaling network and therapeutic developments in breast cancer brain metastasis
por: Benjamin, Mercilena, et al.
Publicado: (2023)

Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer
por: Liu, Kai, et al.
Publicado: (2018)

Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2020)

A Review of Clinical and Preclinical Studies on Therapeutic Strategies Using Interleukin-12 in Cancer Therapy and the Protective Role of Interleukin-12 in Hematological Recovery in Chemoradiotherapy
por: Li, Ping, et al.
Publicado: (2020)

Hypothyroidism Enhances Tumor Invasiveness and Metastasis Development
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2009)

Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
por: Huang, Cheng-Kai, et al.
Publicado: (2020)

Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

From Preclinical Stroke Models to Humans: Polyphenols in the Prevention and Treatment of Stroke
por: Parrella, Edoardo, et al.
Publicado: (2020)

Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis
por: Shah, Neal, et al.
Publicado: (2020)

Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
por: Oshi, Masanori, et al.
Publicado: (2020)

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
por: Arock, Michel, et al.
Publicado: (2018)

Preclinical platforms to study therapeutic efficacy of human γδ T cells
por: Ou, Lingling, et al.
Publicado: (2022)

Re-thinking preclinical models of cancer metastasis
por: Ullo, Maria F., et al.
Publicado: (2018)

Anaesthetics-Induced Neurotoxicity in Developing Brain: An Update on Preclinical Evidence
por: Zhou, Zhaowei, et al.
Publicado: (2014)

Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics
por: Grobler, Jay A., et al.
Publicado: (2020)

Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics
por: Zhou, Haiyan, et al.
Publicado: (2023)

ATRT-11. DEVELOPMENT OF NOVEL PRECLINICAL MODELS AND THERAPEUTIC STRATEGIES FOR ETMR
por: Cocito, Carolina, et al.
Publicado: (2023)

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

The Hidden Brain: Uncovering Previously Overlooked Brain Regions by Employing Novel Preclinical Unbiased Network Approaches
por: Simpson, Sierra, et al.
Publicado: (2021)

Microwave-Based Colonoscopy: Preclinical Evaluation in an Ex Vivo Human Colon Model
por: Fernández-Esparrach, Glòria, et al.
Publicado: (2022)

Cocoa Diet and Antibody Immune Response in Preclinical Studies
por: Camps-Bossacoma, Mariona, et al.
Publicado: (2017)

Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases
por: Martínez-Coria, Hilda, et al.
Publicado: (2019)

Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns
por: Cunningham, Orla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4749bvc299fn8oegottlsg2rd4